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Cystic lung lesions revealing a Pneumocystis jirovecii and Aspergillus
ﬂavus co-infection in an HIV-infected patient
Figure 1. Chest X-ray showing diffuse alveolo-interstitial inﬁltrates (A), and computed tomography (B and C) showing diffuse cystic lesions (asterisks) surrounded by ground-
glass opacities (arrow), and sometimes with thicker walls, mimicking an ‘air crescent sign’ (arrowhead).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j idAn untreated, HIV-infected, 39-year-old woman presented with
a dry cough of 1-month duration. The physical examination was
normal. A chest X-ray showed diffuse alveolo-interstitial inﬁltrates
predominantly in the lung apex (Figure 1A). A computed
tomography (CT) scan disclosed diffuse cystic lesions surrounded
by ground-glass opacities (Figure 1B, C). Some cavitary lesions
presented thicker walls, mimicking an ‘air crescent sign’. The
patient’s CD4 count was 83 cells/ml and HIV viral load was
501 180 copies/ml. Bronchoalveolar lavage (BAL) ﬂuid examina-
tion revealed 360 000 cells/ml, including macrophages (66%),
neutrophils (32%), and eosinophils (2%), with foamy exudates
suggestive of Pneumocystis pneumonia (PCP). Mycological ﬁnd-
ings conﬁrmed Pneumocystis jirovecii cysts and trophic forms,
associated with ﬁlamentous elements with culture of Aspergillus
ﬂavus. Galactomannan antigen was detected in serum and BAL
ﬂuid. Of note, there was no additional predisposing factor for
invasive aspergillosis, in particular no neutropenia or corticoster-
oid therapy.1 Co-trimoxazole was administrated at a curative dose
for 21 days, followed by secondary prophylaxis. Highly-active
antiretroviral therapy was started 10 days later. The probable
pulmonary invasive aspergillosis was treated with voriconazole for
3 months. The patient’s clinical condition improved rapidly.http://dx.doi.org/10.1016/j.ijid.2015.06.021
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Follow-up CT showed progression towards nodular non-cavitary
lesions at 6 weeks, and normalized at 3 months.
Cystic PCP is an unrecognized condition, although involving
more than 30% of patients in some series.2,3 These excavations may
enhance the risk of Aspergillus co-infection, rarely described in
HIV-infected patients.1,4,5
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